药物开发 药物开发
Ralph P Maguire1, William Byrnes2, Matthew E Barton2
1UCB, Braine-l'Alleud, Walloon Brabant, Belgium.
Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 25, 2025
概括
针对的抗体贝普拉尼马布显著减缓了阿尔茨海默病患者大脑中的积. 这项研究提供了第一个临床证据,证明定向疗法减缓了的积累,并证明了临床益处.
科学领域:
- 神经科学是一个神经科学.
- 免疫学 免疫学 免疫学
- 放射学 放射学是一门学科.
背景情况:
- 贝普拉尼马布是一种人性化的单克隆抗体,向人类tau的中部区域.
- 阿尔茨海默氏症 (AD) 的特点是大脑中tau的积累.
- 联合研究 (NCT04867616) 评估了贝普拉尼马布在产生性-轻度AD.
研究的目的:
- 通过PET成像来评估贝普拉尼马布对大脑tau积累的影响.
- 评估贝普拉尼马布在预发性-轻度AD患者的疗效和安全性.
主要方法:
- 随机,安慰剂控制的II期研究,共466名参与者.
- 参与者在80周内每4周内静脉注射贝普拉尼马布 (45或90毫克/公斤) 或安慰剂.
- 使用[18F]GTP1的Tau PET成像在基线,第56周和第80周进行.
主要成果:
- 与安慰剂相比,贝普拉尼马布在第80周在皮质灰色和部区域减缓了tau的积累33-58%,与安慰剂相比.
- 分析包括接受至少部分研究药物并具有有效的基线后评估的参与者.
结论:
- 通过PET成像,TOGETHER研究是第一个通过PET成像通过中部区域tau抗体临床证明tau积累减缓的研究.
- 这标志着定向疗法首次在阿尔茨海默病中显示出临床益处.
更多相关视频
08:04In Vitro Three-Dimensional Sprouting Assay of Angiogenesis Using Mouse Embryonic Stem Cells for Vascular Disease Modeling and Drug Testing
Published on: May 11, 2021
3.3K
05:45Developmental Toxicity Assay Based on Real-Time Monitoring of Fibroblast Growth Factor Signal Disruption in Human Induced Pluripotent Stem Cells
Published on: October 10, 2025
446
相关概念视频
Preclinical Development: Overview
5.7K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
5.7K
Clinical Trials: Overview
4.5K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.5K
Drug Discovery: Overview
10.9K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
10.9K
Drug Administration and Therapy Phases: Overview
1.1K
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
1.1K
In Vitro Drug Release Testing: Overview, Development and Validation
269
In vitro dissolution and drug release tests assess how quickly and how much of a drug is released from its dosage form into an aqueous medium under standardized laboratory conditions. These tests are essential tools in pharmaceutical development and quality assurance, offering insight into the drug's performance before clinical use.During formulation development, dissolution testing identifies incomplete or inconsistent drug release issues. It also supports decisions on selecting the optimal...
269
Drug Regulation
2.7K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
2.7K
